Artificial Intelligence in Kinematics Analysis

Sponsor
Peking University Third Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05443893
Collaborator
(none)
30
1.7

Study Details

Study Description

Brief Summary

  1. Establish data sets. The private data set includes relevant parameters including video of the subject's gait and standard methods for kinematic analysis;

  2. Develop new models. Based on public and private data sets, the kinematic analysis model of human key point detection is further developed.

  3. Test the new model. By comparing the parameters with the standard method, the accuracy of the model was verified, and the kinematics analysis model of artificial intelligence with accuracy above 98% was obtained

Condition or Disease Intervention/Treatment Phase
  • Device: Application Research of key points detection technology

Detailed Description

Artificial intelligence human key point detection model mainly has traditional algorithm, "top-down" algorithm and "bottom-up" algorithm three methods, three methods have advantages. This project will comprehensively use the above three methods to conduct algorithm and parameter debugging in the public data set and test in the private data set, so as to obtain the most suitable human key point recognition method for gait analysis

Study Design

Study Type:
Observational
Anticipated Enrollment :
30 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Application Research of Key Points Detection Technology of Artificial Intelligence in Kinematics Analysis
Anticipated Study Start Date :
Jul 10, 2022
Anticipated Primary Completion Date :
Jul 29, 2022
Anticipated Study Completion Date :
Aug 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Normal subjects

Gait analysis with artificial intelligence and traditional methods

Device: Application Research of key points detection technology
Artificial intelligence human key point detection model mainly has traditional algorithm, "top-down" algorithm and "bottom-up" algorithm three methods, three methods have advantages. This project will comprehensively use the above three methods to conduct algorithm and parameter debugging in the public data set and test in the private data set, so as to obtain the most suitable human key point recognition method for gait analysis

Subjects with abnormal gait

Gait analysis with artificial intelligence and traditional methods

Device: Application Research of key points detection technology
Artificial intelligence human key point detection model mainly has traditional algorithm, "top-down" algorithm and "bottom-up" algorithm three methods, three methods have advantages. This project will comprehensively use the above three methods to conduct algorithm and parameter debugging in the public data set and test in the private data set, so as to obtain the most suitable human key point recognition method for gait analysis

Outcome Measures

Primary Outcome Measures

  1. Gait related parameters [30mins]

    Step frequency/pace/gait cycle/step length

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
    1. Abnormal gait.
  • Can walk 6m or more independently.

  • Older than 18.

Exclusion Criteria:
  • Fracture may be aggravated by walking in the acute stage or early postoperative stage. Have heart, lung, liver and kidney And other serious diseases, heart function grading greater than GRADE I (NYHA), respiratory failure and other symptoms and signs or Check the results.

  • The mental and psychological state cannot cooperate with the completion of the experiment.

  • High risk of falls (Berg score ≤20)

  • Gait kinematics analysis equipment cannot be used together.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Peking University Third Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zhou Mouwang, Professor, Peking University Third Hospital
ClinicalTrials.gov Identifier:
NCT05443893
Other Study ID Numbers:
  • M2021231
First Posted:
Jul 5, 2022
Last Update Posted:
Jul 5, 2022
Last Verified:
Jul 1, 2022

Study Results

No Results Posted as of Jul 5, 2022